Ibaraki, Japan

Mamoru Yanagimachi

USPTO Granted Patents = 2 

Average Co-Inventor Count = 11.0

ph-index = 2

Forward Citations = 18(Granted Patents)


Company Filing History:


Years Active: 2003-2006

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Inventor Mamoru Yanagimachi: Innovator in Pharmaceutical Chemistry

Introduction

Mamoru Yanagimachi is a distinguished inventor based in Ibaraki, Japan. With a focus on pharmaceutical chemistry, he has contributed significantly to the field with his patented innovations. His work revolves around novel compounds that have potential therapeutic applications.

Latest Patents

Yanagimachi holds two patents, showcasing his inventive expertise. His most recent patent describes an N-aryl-substituted cyclic amine derivative that serves as an excellent squalene synthase inhibitor. The details outline a compound represented by a specific formula where R signifies an optionally substituted vinyl group or an aromatic ring. The intricate structural formula also involves variables such as n, X, Y, Z, and CyA, indicating a broad scope of chemical possibilities.

Career Highlights

Currently, Yanagimachi is employed at Eisai Company, Limited, a leading global biopharmaceutical company focused on developing innovative medicines. His role highlights his commitment to advancing healthcare through cutting-edge research and development.

Collaborations

During his career, Yanagimachi has collaborated with notable colleagues, including Toshimi Okada and Nobuyuki Kurusu. These partnerships foster an environment of innovation, leading to valuable advancements in drug development and therapeutic solutions.

Conclusion

Mamoru Yanagimachi's contributions to the field of pharmaceutical chemistry underscore his importance as an inventor. His patents reflect a commitment to innovation and a deep understanding of complex chemical interactions, paving the way for future breakthroughs in medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…